Ethofylline & Theophylline Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 84.7 mg Ethofylline + 25.3 mg Theophylline
Reference Brands: Deriphyllin® , Derin®
Category:
Respiratory Disorder
Ethofylline and Theophylline Injection is a fast-acting bronchodilator used for acute asthma and COPD attacks. Common in India under brands like Deriphyllin® and Derin®, each 2 mL ampoule contains 84.7 mg Ethofylline + 25.3 mg Theophylline. It’s given via IV/IM for quick respiratory relief in emergencies.
Ethofylline & Theophylline is available in Injection
and strengths such as 84.7 mg Ethofylline + 25.3 mg Theophylline.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ethofylline & Theophylline is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ethofylline & Theophylline can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ethofylline and Theophylline Injection is a bronchodilator combination used for the rapid relief of acute asthma attacks and COPD exacerbations. It works by relaxing the airway muscles, improving airflow, and easing breathing. Commonly available in India under brands like Deriphyllin®, Derin®, Bronkolid, and Etofylline-T, each 2 mL ampoule typically contains 84.7 mg Ethofylline and 25.3 mg Theophylline. Administered via IV or IM, this medication is widely used in emergency settings. Though not commonly marketed in the US or EU, it plays a vital role in respiratory care across developing countries due to its fast action and affordability.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing